The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users.
about
Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practiceComputer-enhanced interventions for drug use and HIV risk in the emergency room: preliminary results on psychological precursors of behavior change.Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.Prevalence and correlates of HIV risk among adolescents and young adults reporting drug use: Data from an urban Emergency Department in the U.S.Smartphone Delivery of Mobile HIV Risk Reduction Education.General and health-related Internet use among an urban, community-based sample of HIV-positive women: implications for intervention development.Group-based randomized trial of contingencies for health and abstinence in HIV patientsThe provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic reviewThe impact of childhood abuse on inpatient substance users: specific links with risky sex, aggression, and emotion dysregulation.Injection drug use as a mediator between client-perpetrated abuse and HIV status among female sex workers in two Mexico-US border citiesClub drug use in Hispanic college studentsAlcohol use and gender effects on HIV risk behaviors in cocaine-using methadone patientsScaling sexual behavior or "sexual risk propensity" among men at risk for HIV in Kisumu, Kenya.Prevalence of HIV among injection drug users in GeorgiaAssociations between impulsivity and high risk sexual behaviors in dually diagnosed outpatientsIntimate Partner Violence among Female Sex Workers in Two Mexico-U.S. Border Cities: Partner Characteristics and HIV Risk-behaviors as Correlates of Abuse.On beyond urine: clinically useful assessment instruments in the treatment of drug dependence.Exercise for methamphetamine dependence: rationale, design, and methodology.Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: results from the National Drug Abuse Treatment Clinical Trials Network.Advantages of Joint Modeling of Component HIV Risk Behaviors and Non-Response: Application to Randomized Trials in Cocaine-Dependent and Methamphetamine-Dependent Populations.HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.Gender differences in the rates and correlates of HIV risk behaviors among drug abusers.Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.An Evaluation of Substance Abuse Treatment and HIV Education on Safe Sex Practices in Cocaine Dependent IndividualsAvoiding risky sex partners: perception of partners' risks v partners' self reported risks.Is monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerationsThe moderating effects of cannabis use and decision making on the relationship between conduct disorder and risky sexual behavior.Delay and probability discounting of sexual and monetary outcomes in individuals with cocaine use disorders and matched controls.Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, ChinaDrug-related behaviors independently associated with syphilis infection among female sex workers in two Mexico-US border cities.The Sexual Discounting Task: HIV risk behavior and the discounting of delayed sexual rewards in cocaine dependenceGendered Pathways: Violent Childhood Maltreatment, Sex Exchange, and Drug UseCo-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence.Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.The contribution of emotion regulation difficulties to risky sexual behavior within a sample of patients in residential substance abuse treatmentDepressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network.Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in ChinaCorrelates of Opioid Use in Adults With Self-Reported Drug Use Recruited From Public Safety-Net Primary Care Clinics.Selection and utilization of assessment instruments in substance abuse treatment trials: the National Drug Abuse Treatment Clinical Trials Network experience.
P2860
Q24645023-B5C0F2FA-7A42-4D61-8547-E610D16C33F1Q30572035-345CF42C-18E3-428F-B915-CA2054A31BF4Q30667437-1ABEC0D1-6721-46C2-B1F6-4E4DE2513553Q30831694-8B14F213-6BEA-4842-9290-DCCDCE92F4F4Q30842951-7E0F3DC4-2DA1-4A8C-8841-DB8BEECEDFA7Q33440185-E9D608AF-5D39-4B97-801A-2465AD86F0C6Q33442103-90155FD0-2267-4C9D-9545-34DE93CE3493Q33618807-D65921D5-341A-47EC-9BEA-555D77E4DCF4Q33752193-22D927DC-CF2A-438A-9B6E-8833F25D6850Q33784813-21A4525B-6049-4A15-9B79-B7CAA3DB57D4Q33926802-2750E403-09CB-4A79-8D11-71F5C55E4C04Q34026587-FE0E980E-067E-49A6-A3F5-06729208208BQ34051233-4CEAE950-7C84-401B-838A-05B32D44A216Q34395510-321CA034-DEB4-4EB3-ACC5-C9C4D91EEF19Q34633313-55E1D96B-A557-4035-A0CF-361A55B04401Q34718527-BE61F493-BBBE-4FCC-9A4E-940139CDCDB5Q34867692-1536B45D-CB4E-4DB4-997F-CB93BF015EBAQ34971483-3F6595C6-5E23-4565-BE31-BDE8AAFF18EFQ35056994-E73781AF-6B47-466C-B21A-EE1210EDE167Q35065975-4D9EAE17-9445-4734-ABA3-AFDAF3A1563AQ35098069-8326B6B8-4CD6-4B13-8174-EF37B1DAC9E6Q35143605-F81F0C8D-0C8F-4B7D-AD14-1CD656682722Q35203629-AE1D372E-57DD-40B6-8B1E-31CCA00E6BFDQ35206845-841758BA-2E02-4B00-8AA3-7FECA5A539A3Q35361310-7CAE395F-AE55-4983-BEF3-3CD7375014B2Q35530542-1790564E-FDC7-4687-BBE0-E659DE814323Q35615816-BA092EB9-29D0-4341-984D-8D617F4A6030Q35639048-017FEB74-0862-40FD-A6BA-AD8331D8AF96Q35643458-D71E0E41-03F7-4A37-A530-7E077161499FQ35773225-5C44C8C3-972E-4AB5-AC76-41C83ACC6847Q35775863-1B765729-5B9E-480A-ABAA-6225C003DAD0Q35791037-61A4FA2F-5D29-4A1C-96F4-34A29081DAF9Q35896675-F3682629-B584-43A6-9D68-F6B6C2229E17Q35917862-4022969E-B65E-4243-94E4-DFE27A5819B8Q35924202-7C988A46-5C98-496B-B148-F201142C4E08Q36074535-77BF4E16-04FD-4F16-AADA-A43469300DC6Q36089195-1356CFC8-FCB3-484E-9DEB-6AE72CAC5B76Q36113425-AB2F616D-3F72-4888-801F-0B1A7A371E2BQ36163633-DDA00498-35B0-466D-853F-B6D34EB47A07Q36165376-21FEB067-6B98-4F14-B54B-761A6DDE4E14
P2860
The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
The reliability and validity o ...... among intravenous drug users.
@en
The reliability and validity o ...... among intravenous drug users.
@nl
type
label
The reliability and validity o ...... among intravenous drug users.
@en
The reliability and validity o ...... among intravenous drug users.
@nl
prefLabel
The reliability and validity o ...... among intravenous drug users.
@en
The reliability and validity o ...... among intravenous drug users.
@nl
P2093
P1433
P1476
The reliability and validity o ...... among intravenous drug users.
@en
P2093
P304
P407
P577
1991-02-01T00:00:00Z